ECOR
electroCore, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$8.00
+10.58%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$7.19
From 52W high−34.95%
Volume154249.00
Market cap$72.08M
P/E (TTM)—
P/S (TTM)1.9x
Div yield—
Key dataNov 4, 2026
Open
$7.19
From 52W high
−34.95%
Volume
154249.00
Market cap
$72.08M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−5.7x
P/E (TTM)
—
RSI (14)
37.4
MomentumView details →
1D Return
+10.58%
YTD Return
+63.47%
SummaryUpdated Jun 1, 2026
electroCore, Inc. (NASDAQ:ECOR) is a commercial-stage medical device company founded in 2005 and headquartered in Rockaway, New Jersey. The company specializes in developing and commercializing non-invasive vagus nerve stimulation (nVNS) therapies through its flagship gammaCore technology platform. Since going public in 2018, electroCore has expanded beyond prescription medical devices into direct-to-consumer wellness products and military performance applications. In 2024, the company strategically acquired NeuroMetrix to broaden its bioelectronic health portfolio, positioning itself as a diversified player in the emerging field of bioelectronic medicine.
Similar companies
Latest newsMore news →
electroCore announced that it will report financial results for the third quarter ended September 30, 2026, after the market closes on November 4, 2026.6d agoelectroCore submitted a 510(k) premarket notification to the U.S. Food and Drug Administration seeking clearance of its Quell wearable neuromodulation platform to treat chronic chemotherapy-induced peripheral neuropathy.7d ago